Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present AXM Pharma, Inc. (OTC: AXMP).

Full DD Report for AXMP

You must become a subscriber to view this report.


Recent News from (OTC: AXMP)

AXM Pharma Issues Correction
NEW YORK, July 06, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- AXM Pharma, Inc. (OTC:AXMP) (“AXM Pharma” or the “Company”) on July 02, 2018 announced that it entered into a binding letter agreement (the “Letter Agreement”) with a leading Cameroon-ba...
Source: GlobeNewswire
Date: July, 06 2018 20:31
AXM Pharma announces the appointment of a new CEO
AXM Pharma ( OTCPK:AXMP ) appointed Linda L. Forster as the new Chief Executive Officer effective immediately, replacing Mandla J. Gwadiso. More news on: AXM Pharma, Inc., Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: July, 03 2018 14:09
AXM Pharma Announces the Appointment of a New Chief Executive Officer
NEW YORK, July 03, 2018 (GLOBE NEWSWIRE) -- AXM Pharma, Inc. (OTC:AXMP) (“ AXM Pharma ” or the “ Company ”) is pleased to announce that its Chairman, Mr. Emmanuel Neossi, has appointed Linda L. Forster as the new Chief Executive Officer effective immediately. As...
Source: GlobeNewswire
Date: July, 03 2018 13:13
AXM Pharma agrees to reverse merger with Cameroon cocoa exporter; shares up 118%
Thinly traded nano cap AXM Pharma ( OTCPK:AXMP +117.6% ) rockets on a healthy 18x surge in volume in response to its announcement that it has inked a binding letter agreement for a reverse takeover by privately held AS Industries Cameroon (ASIC), a cocoa exporter. More news on: AXM Pha...
Source: SeekingAlpha
Date: July, 02 2018 15:20
AXM Pharma Announces A Proposed Reverse Merger with A Cameroon Billionaire Businessman
NEW YORK, July 02, 2018 (GLOBE NEWSWIRE) -- AXM Pharma, Inc. (OTC:AXMP) (“ AXM Pharma ” or the “ Company ”) is pleased to announce that it has entered into a binding letter agreement dated as of June 14, 2018 (the “ Letter Agreement ”) with a leadin...
Source: GlobeNewswire
Date: July, 02 2018 12:59

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-13N/A0.005N/AN/A0
2018-12-120.0050.0050.0050.000524,250
2018-12-11N/A0.0009N/AN/A0
2018-12-10N/A0.0009N/AN/A26
2018-12-07N/A0.0009N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-11-2710,00054,53518.3368Cover
2018-11-2110,00020,00050.0000Short
2018-10-3150,000188,20926.5662Cover
2018-10-045,0007,94662.9247Short
2018-09-2410018,1000.5525Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on AXMP.


About AXM Pharma, Inc. (OTC: AXMP)

Logo for AXM Pharma, Inc. (OTC: AXMP)

Not available

 

Contact Information

 

 

Current Management

  • Joseph Arcaro / CEO, CFO, Secretary
  • Trisha Bollman / Consultant
  • Joseph Arcaro /

Current Share Structure

  • Market Cap: $2,125,278 - 03/12/2018
  • Authorized: 800,000,000 - 08/18/2015
  • Issue and Outstanding: 158,602,838 - 08/18/2015

 



Daily Technical Chart for (OTC: AXMP)

Daily Technical Chart for (OTC: AXMP)


Stay tuned for daily updates and more on (OTC: AXMP)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: AXMP)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AXMP is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of AXMP and does not buy, sell, or trade any shares of AXMP. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/